A G Edlow1, L Hui1,2, H C Wick3, I Fried3, D W Bianchi1. 1. Mother Infant Research Institute and Department of Obstetrics and Gynecology, Tufts Medical Center, Boston, MA, USA. 2. Department of Perinatal Medicine, Mercy Hospital for Women, Heidelberg, Vic., Australia. 3. Department of Computer Science, Tufts University, Medford, MA, USA.
Abstract
OBJECTIVE: To analyse fetal gene expression at term using umbilical cord blood, in order to provide insights into the effects of maternal obesity on human development. DESIGN: Prospective case-control study. SETTING: Academic tertiary care centre. POPULATION: Eight obese (body mass index ≥30 kg/m(2)) and eight lean (body mass index <25 kg/m(2)) pregnant women undergoing prelabour caesarean delivery at term. METHODS: Women were matched for gestational age and fetal sex. Cord blood RNA was extracted and hybridised to gene expression arrays. Differentially regulated genes were identified using paired t-tests and the Benjamini-Hochberg correction. Functional analyses were performed using Ingenuity Pathway Analysis, BioGPS and Gene Set Enrichment Analysis with a fetal-specific annotation. Z-scores ≥2.0 or P-values <0.01 were considered significant. MAIN OUTCOME MEASURE: Functions of differentially regulated genes in fetuses of obese women. RESULTS: A total of 701 differentially regulated genes were identified, producing an expression profile implicating neurodegeneration, decreased survival of sensory neurons, and decreased neurogenesis in the fetuses of obese women. Upstream regulators related to inflammatory signalling were significantly activated; those related to insulin receptor signalling, lipid homeostasis, regulation of axonal guidance, and cellular response to oxidative stress were significantly inhibited. Of 26 tissue-specific genes that were differentially regulated in fetuses of obese women, six mapped to the fetal brain. CONCLUSION: Maternal obesity affects fetal gene expression at term, implicating dysregulated brain development, inflammatory and immune signalling, glucose and lipid homeostasis, and oxidative stress. This may have implications for postnatal neurodevelopment and metabolism.
OBJECTIVE: To analyse fetal gene expression at term using umbilical cord blood, in order to provide insights into the effects of maternal obesity on human development. DESIGN: Prospective case-control study. SETTING: Academic tertiary care centre. POPULATION: Eight obese (body mass index ≥30 kg/m(2)) and eight lean (body mass index <25 kg/m(2)) pregnant women undergoing prelabour caesarean delivery at term. METHODS:Women were matched for gestational age and fetal sex. Cord blood RNA was extracted and hybridised to gene expression arrays. Differentially regulated genes were identified using paired t-tests and the Benjamini-Hochberg correction. Functional analyses were performed using Ingenuity Pathway Analysis, BioGPS and Gene Set Enrichment Analysis with a fetal-specific annotation. Z-scores ≥2.0 or P-values <0.01 were considered significant. MAIN OUTCOME MEASURE: Functions of differentially regulated genes in fetuses of obesewomen. RESULTS: A total of 701 differentially regulated genes were identified, producing an expression profile implicating neurodegeneration, decreased survival of sensory neurons, and decreased neurogenesis in the fetuses of obesewomen. Upstream regulators related to inflammatory signalling were significantly activated; those related to insulin receptor signalling, lipid homeostasis, regulation of axonal guidance, and cellular response to oxidative stress were significantly inhibited. Of 26 tissue-specific genes that were differentially regulated in fetuses of obesewomen, six mapped to the fetal brain. CONCLUSION:Maternal obesityaffects fetal gene expression at term, implicating dysregulated brain development, inflammatory and immune signalling, glucose and lipid homeostasis, and oxidative stress. This may have implications for postnatal neurodevelopment and metabolism.
Authors: J Saben; F Lindsey; Y Zhong; K Thakali; T M Badger; A Andres; H Gomez-Acevedo; K Shankar Journal: Placenta Date: 2014-01-11 Impact factor: 3.481
Authors: Aravind Subramanian; Pablo Tamayo; Vamsi K Mootha; Sayan Mukherjee; Benjamin L Ebert; Michael A Gillette; Amanda Paulovich; Scott L Pomeroy; Todd R Golub; Eric S Lander; Jill P Mesirov Journal: Proc Natl Acad Sci U S A Date: 2005-09-30 Impact factor: 11.205
Authors: Bo Sun; Ryan H Purcell; Chantelle E Terrillion; Jianqun Yan; Timothy H Moran; Kellie L K Tamashiro Journal: Diabetes Date: 2012-06-29 Impact factor: 9.461
Authors: Keshari M Thakali; Jessica Saben; Jennifer B Faske; Forrest Lindsey; Horacio Gomez-Acevedo; Curtis L Lowery; Thomas M Badger; Aline Andres; Kartik Shankar Journal: Pediatr Res Date: 2014-05-12 Impact factor: 3.756
Authors: Luca Meoli; Nitin K Gupta; Nima Saeidi; Courtney A Panciotti; Sudha B Biddinger; Kathleen E Corey; Nicholas Stylopoulos Journal: Am J Physiol Endocrinol Metab Date: 2018-02-20 Impact factor: 4.310
Authors: Andrea G Edlow; Faycal Guedj; Jeroen L A Pennings; Deanna Sverdlov; Caterina Neri; Diana W Bianchi Journal: Am J Obstet Gynecol Date: 2016-03-03 Impact factor: 8.661
Authors: Andrea G Edlow; Faycal Guedj; Deanna Sverdlov; Jeroen L A Pennings; Diana W Bianchi Journal: Front Neurosci Date: 2019-12-17 Impact factor: 4.677
Authors: In-Uk Koh; Nak-Hyeon Choi; Kibaick Lee; Ho-Yeong Yu; Jun Ho Yun; Jin-Hwa Kong; Hyo Jin Kim; Song Lee; Song Cheol Kim; Bong-Jo Kim; Sanghoon Moon Journal: BMJ Open Diabetes Res Care Date: 2020-08